Research Article
Volume 13 Issue 5 - 2021
Recovering Cognitive Deficit in Epilepsy: Innovative “BrainNext” Tools Program at Epilepsy Foundation, India
Mangal Shirish Kardile1 and Nirmal Surya2*
1Consulting Neuropsychologist, Epilepsy Foundation, Sancheti Hospital, Mental Health Aims, Nashik, India
2Assistant Professor, Department of Neurology, Bombay Hospital Institute of Medical Sciences and Epilepsy Foundation, Mumbai, India
*Corresponding Author: Nirmal Surya, Assistant Professor, Department of Neurology, Bombay Hospital Institute of Medical Sciences and Epilepsy Foundation, Mumbai, India.
Received: March 05, 2021; Published: April 23, 2021


Introduction: Epilepsy is observed at any age from a newborn infant to elder adults, having long term effects on physical, psychological and cognitive capacity of the affected individual [1,2]. Epilepsy causes significant cognitive impairment and the longest YLD as compared to other neurological population [3,4]. This study focuses on 19 months systematic cognitive rehab program for 152 epilepsy patients, using "BrainNext", tools, the concept based on synaptic plasticity [3].

Materials and Methods: Based on clinical history of Epilepsy Patients N = 152, ages 2.6 to 45 were tested and given memory and cognitive training program using innovative Global and National award winning “BrainNext” tools at “Epilepsy Foundation”, India. Patients belonged to varied socio-economic, educational and cultural backgrounds. The caregiver was trained, covering 2 to 3 cognitive domains at a time as applicable with certain time duration follow-ups for 4 to 5 months. To measure the progress, 1 to 10 rating scale was used, score 1 as 10% and 10 as 100% recovery. 0% was set as the baseline condition for all.

Results and Discussion: Responses evaluated at each follow-up, Caregiver support and regular follow-up. Patients N = 66 for 4 months improved memory, cognitive and behavior responses > 45% to 80% from the baseline condition, amongst 26 improved up-to caregiver’s satisfaction needed no further visits. Patients N = 80 with moderate caregiver support, intermittent gaps and irregular follow-up for 9 months improved memory, cognitive tasks and behavior with 25% to 55% from the baseline condition, excluded N=6 patients with < 15 days training.

Conclusion: “BrainNext” award winning tools are safe, durable, easy to use, yield positive results apart from YLD of patient. Besides uncontrolled seizures and cognitive disability the patient and caregiver could follow cognitive rehab with own pace, without barrier, improving cognitive learning capacity, lessening caregiver’s burden. Patients having developmental disorders built sensory capacity for pain and temperature and the sense of “cautiousness” for the first-time. Overall patients improved in speech, attention, concentration, stability, emotional expression and motor control improving quality of life.

Keywords: Epilepsy; Seizures; Memory; Cognitive; BrainNext; Neurorehabilitation


  1. Bruce Hermann and Michael Seidenberg. “Epilepsy and Cognition”. Epilepsy Current1 (2007): 1-6.
  2. Greener M. “Beyond seizures: understanding cognitive deficits in epilepsy”. Progress in Neurology and Psychiatry (2013).
  3. Kardile M. “Excellence in diagnosis in culturally diverse settings: the development of Universal Memory and Cognitive Exam (UMACE)”. Oral presentation at "The 26th Annual Conference of Alzheimer Europe" Copenhagen, Denmark Alzheimer’s Europe (2016).
  4. Kardile M., et al. “The development of a new screening tool for cognitive impairment in India: the universal memory and cognitive exam (UMACE)”. International Journal of Health Sciences and Research 5 (2018): 226-234.
  5. Kardile M and Surya N. “Epilepsy and Cognitive rehabilitation >125 patients”. Award paper 27th Annual Conference IANCON (2019): Indian Academy of Neurology: Hyderabad (2019).
  6. Kardile M and Surya N. “Epilepsy Case study oral presentation”. 7th Annual Conference IFNRCON 2019- Indian Federation of Neurorehabilitation and Neurorehab Sub-Section of Indian Academy of Neurology, Mumbai (2019).
  7. Nirmal Surya., et al. “Comprehensive Epilepsy care during the lockdown due to COVID-19 Pandemic in INDIA: Epilepsy Foundation India Model”. International Journal of Current Research07 (2020): 12159-12162.
  8. Kardile M and Sancheti K. “Memory Recall and Cognitive Recovery for Alzheimer’s and Dementia: A Systematic Neurorehabilitation Program for 42 Dementia Patients Using “BrainNext” Tools at Sancheti Hospital, Pune, India”. EC Neurology7 (2020): 48-56.
  9. Kardile M and Surya N. “Epilepsy Case study poster presentation”. 21st Joint Annual Conference ECON (2020): Indian Epilepsy Association and Indian Epilepsy Society: Ahmedabad (2020).
Citation: Mangal Shirish Kardile and Nirmal Surya. “Recovering Cognitive Deficit in Epilepsy: Innovative “BrainNext” Tools Program at Epilepsy Foundation, India”. EC Neurology 13.5 (2021): 82-92.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 08, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to